Navigation Links
Notice of conference call and webcast
Date:10/28/2008


THIRD QUARTER 2008 FINANCIAL RESULTS

Confirmation of Annual and Special General Meeting of Shareholders

VANCOUVER, Oct. 28 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the third quarter ended September 30, 2008 on Thursday, November 6, 2008 at 11:00 AM ET (8:00 AM Pacific).

The Company's Annual and Special General Meeting of Shareholders is confirmed for Thursday, October 30, 2008 at 11:30 AM ET (8:30 AM Pacific). Due to the proximity of the earnings conference call, there will be no management update at the Annual and Special General Meeting of Shareholders; and therefore, the meeting will not be made available via webcast or conference call.

Dial information for the earnings call on November 6, 2008 is as follows:

North America (toll-free): (866) 383-7998

International: (617) 597-5329

Enter passcode: 11247654

A live webcast of the earnings conference call will be available to all interested parties through Angiotech's website at http://www.angiotech.com in the Investor Relations section.

A press release announcing Angiotech's financial results will be issued prior to the conference call on November 6 at approximately 8:00 AM ET (5:00 AM Pacific).

A replay archive of the conference call will be available until November 13, 2008.

Replay information is as follows:

North America: (888) 286-8010

International: (617) 801-6888

Enter passcode: 75181409

About Angiotech Pharmaceuticals

Angi
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
2. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
3. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
4. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
5. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
6. YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS
7. Maxygen Third Quarter 2007 Financial Results Conference Call Notice
8. Notice of Conference Call and Webcast
9. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
10. Healthcare Technologies, Ltd. Receives Notice From Nasdaq
11. Tapestry Receives Notice Regarding Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... November 26, 2014 PMG Research, Inc. ... PMG Research is a network of sites that provide clinical ... over 2 million patient lives through its partnerships with large ... of 11 hub site locations in the Southeastern United States ... term of the board will be held by: ...
(Date:11/26/2014)... Silicon Valley Electronic Data Capture (EDC) provider ... provider of clinical research and data management services to ... its CRO Partnership Program, Clinovo expands ClinCapture , ... , “We have found Clinovo’s ClinCapture to exceed our ... is both user friendly and easy to deploy. The ...
(Date:11/26/2014)... 25, 2014 Global biostimulants market ... growing at an estimated CAGR of 12.5%. In ... food products with least ecological impacts, farmers are ... to boost crop yield more effectively & efficiently. ... can improve the return on investments. , Leading ...
(Date:11/26/2014)... and WILMINGTON, DE (PRWEB) November 26, 2014 ... Annual MPN Heroes recognition reception on December 5, 2014, ... Hematology’s annual meeting. The MPN Heroes event will honor ... in the field of myeloproliferative neoplasms (MPNs). , ... "Nashville," will discuss his family's cancer journey at the ...
Breaking Biology Technology:PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 22019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 22019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 32019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 4CURE Magazine and Incyte to Honor MPN Heroes 2CURE Magazine and Incyte to Honor MPN Heroes 3CURE Magazine and Incyte to Honor MPN Heroes 4
... Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced its financial results,and ... 31, 2008., "We are currently enrolling or ... four exploring the use of REOLYSIN(R) as a ... combination with a variety of,chemotherapies, immune modulation and ...
... batch of bluetongue Bovilis BTV8 vaccine released to supply Northern ... ... Animal Health (NYSE: SGP ) released the first batch,of Bovilis ... company, combining after the acquisition in 2007 the,strength of Intervet and ...
... BOSTON, April 30 Today John C. Lechleiter,Ph.D., ... (NYSE: LLY ), provided,insight into the future ... that,key players, significant investments in the sector are ... Conference, a gathering of,policymakers, business leaders and academics, ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces 2008 First Quarter Results 2Oncolytics Biotech Inc. Announces 2008 First Quarter Results 3Oncolytics Biotech Inc. Announces 2008 First Quarter Results 4Oncolytics Biotech Inc. Announces 2008 First Quarter Results 5Oncolytics Biotech Inc. Announces 2008 First Quarter Results 6Oncolytics Biotech Inc. Announces 2008 First Quarter Results 7Oncolytics Biotech Inc. Announces 2008 First Quarter Results 8Oncolytics Biotech Inc. Announces 2008 First Quarter Results 9Oncolytics Biotech Inc. Announces 2008 First Quarter Results 10Oncolytics Biotech Inc. Announces 2008 First Quarter Results 11Oncolytics Biotech Inc. Announces 2008 First Quarter Results 12Oncolytics Biotech Inc. Announces 2008 First Quarter Results 13Oncolytics Biotech Inc. Announces 2008 First Quarter Results 14Oncolytics Biotech Inc. Announces 2008 First Quarter Results 15Oncolytics Biotech Inc. Announces 2008 First Quarter Results 16Oncolytics Biotech Inc. Announces 2008 First Quarter Results 17Oncolytics Biotech Inc. Announces 2008 First Quarter Results 18Oncolytics Biotech Inc. Announces 2008 First Quarter Results 19Oncolytics Biotech Inc. Announces 2008 First Quarter Results 20Oncolytics Biotech Inc. Announces 2008 First Quarter Results 21Oncolytics Biotech Inc. Announces 2008 First Quarter Results 22Oncolytics Biotech Inc. Announces 2008 First Quarter Results 23Oncolytics Biotech Inc. Announces 2008 First Quarter Results 24Oncolytics Biotech Inc. Announces 2008 First Quarter Results 25Oncolytics Biotech Inc. Announces 2008 First Quarter Results 26Oncolytics Biotech Inc. Announces 2008 First Quarter Results 27Oncolytics Biotech Inc. Announces 2008 First Quarter Results 28Oncolytics Biotech Inc. Announces 2008 First Quarter Results 29Oncolytics Biotech Inc. Announces 2008 First Quarter Results 30Oncolytics Biotech Inc. Announces 2008 First Quarter Results 31Oncolytics Biotech Inc. Announces 2008 First Quarter Results 32Oncolytics Biotech Inc. Announces 2008 First Quarter Results 33Intervet/Schering-Plough Animal Health Outlines Strength of the Combination 2Intervet/Schering-Plough Animal Health Outlines Strength of the Combination 3Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth 2
(Date:11/5/2014)... – Kelly Redmond has dedicated his career to ... to a general audience. , As deputy director ... Center at Nevada,s Desert Research Institute, Redmond has ... management, application and dissemination of climate data to ... Fall Meeting in San Francisco on December 15-19, ...
(Date:11/4/2014)... Temple University School of Medicine announced today that ... initiative funded by the Bill & Melinda Gates ... Obstetrics, Gynecology and Reproductive Sciences; and Vice Chair ... School of Medicine will pursue an innovative global ... Biomarkers to Assess Fetal Neurodevelopment.", Grand Challenges Explorations ...
(Date:11/4/2014)... majority of Madagascar,s 101 species of lemurs are threatened ... the rainforests they call home. A new study by ... have on rainforest tree populations, which raises concerns about ... region,s rich biodiversity. , A large proportion of trees ... Lemurs in turn disperse the seeds of their fruit ...
Breaking Biology News(10 mins):Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2Temple University School of Medicine receives Grand Challenges Explorations grant 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... be used to produce an organic substrate for use in ... advantage that it can be recycled and is more economic ... , These are the findings of researchers at the ... in Ziordia (Navarre), have developed this substrate material. The product ...
... University of Manchester have created a new type of 'bio-gel' ... 3D, as published in the journal Advanced Materials (March 2006). ... from combinations of dipeptides (pairs of amino acids) to provide ... conditions. , Uniquely, the gel mimics the properties of cell ...
... of human DNA have different structures that are treated differently ... found in a study that could help lead to cancer ... issue of the journal Molecular Cell ?focuses on the ends ... time the cell divides, the telomeres shorten. When they become ...
Cached Biology News:New organic substrate 2Manchester scientists create new bio-gel for 3D cell culture 2DNA end caps may lead to cancer treatments, UT Southwestern researchers report 2
... System provides a simple, rapid and ... glutathione-S-transferase (GST) fusion proteins. Immobilized glutathione ... to isolate GST-tagged protein directly from ... either a manual (requires use of ...
... compact, versatile system that simultaneously harvests and ... microplates into a solid filter supports for ... gamma counter. The FilterMate is ideal for ... as cell proliferation, receptor binding, nucleic acid ...
... based screening project: , 384 ... 96 shape-diverse mixtures of 4 (5 uL each) , ... Individual compounds are dissolved in DMSO at ... Supplied in 5 96-well trays. Dilute library with ...
... Detection Kit (Catalog number SCR004) is a ... assessment of ES cell differentiation by the ... from CHEMICON are the monoclonal antibodies TRA-2-49 ... MAB4354), which permit the detection of Liver ...
Biology Products: